{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:23:52Z","timestamp":1790760232593,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Several tumor-derived factors have been implicated in dendritic cell (DC) dysfunction in cancer patients. \u03b1-fetoprotein (AFP) is an oncofetal Ag that is highly expressed in abnormalities of prenatal development and several epithelial cancers, including hepatocellular carcinoma (HCC). In HCC patients exhibiting high levels of serum AFP, we observed a lower ratio of myeloid\/plasmacytoid circulating DCs compared with patients with low serum AFP levels and healthy donors. To test the effect of AFP on DC differentiation in vitro, peripheral blood monocytes from healthy donors were cultured in the presence of cord blood\u2013derived normal AFP (nAFP) or HCC tumor-derived AFP (tAFP), and DC phenotype and function were assessed. Although the nAFP and tAFP isoforms only differ at one carbohydrate group, low (physiological) levels of tAFP, but not nAFP, significantly inhibited DC differentiation. tAFP-conditioned DCs expressed diminished levels of DC maturation markers, retained a monocyte-like morphology, exhibited limited production of inflammatory mediators, and failed to induce robust T cell proliferative responses. Mechanistic studies revealed that the suppressive activity of tAFP is dependent on the presence of low molecular mass (LMM) species that copurify with tAFP and function equivalently to the LMM fractions of both tumor and nontumor cell lysates. These data reveal the unique ability of tAFP to serve as a chaperone protein for LMM molecules, both endogenous and ubiquitous in nature, which function cooperatively to impair DC differentiation and function. Therefore, novel therapeutic approaches that antagonize the regulatory properties of tAFP will be critical to enhance immunity and improve clinical outcomes.<\/jats:p>","DOI":"10.4049\/jimmunol.1400725","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T03:03:14Z","timestamp":1414638194000},"page":"5723-5732","source":"Crossref","is-referenced-by-count":86,"title":["Tumor-Derived \u03b1-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic Cells"],"prefix":"10.1093","volume":"193","author":[{"given":"Angela D","family":"Pardee","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Pittsburgh School of Medicine , Pittsburgh, PA 15213"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh School of Medicine , Pittsburgh, PA 15213"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa H","family":"Butterfield","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh School of Medicine , Pittsburgh, PA 15213"},{"name":"Department of Immunology, University of Pittsburgh School of Medicine , Pittsburgh, PA 15213"},{"name":"Department of Surgery, University of Pittsburgh School of Medicine , Pittsburgh, PA 15213"},{"name":"University of Pittsburgh Cancer Institute , Pittsburgh, PA 15213"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"2025030707475535700_r1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.me.28.020177.002321","article-title":"Structure and function of alpha-fetoprotein","volume":"28","author":"Tomasi","year":"1977","journal-title":"Annu. Rev. Med."},{"key":"2025030707475535700_r2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1586\/14737140.2.6.709","article-title":"Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy","volume":"2","author":"Mizejewski","year":"2002","journal-title":"Expert Rev. Anticancer Ther."},{"key":"2025030707475535700_r3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.bjc.6690828","article-title":"Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour","volume":"81","author":"Johnson","year":"1999","journal-title":"Br. J. Cancer"},{"key":"2025030707475535700_r4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/153537020122600503","article-title":"Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants","volume":"226","author":"Mizejewski","year":"2001","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"2025030707475535700_r5","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/ijc.24272","article-title":"Alpha fetoprotein is a novel protein-binding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells","volume":"124","author":"Li","year":"2009","journal-title":"Int. J. Cancer"},{"key":"2025030707475535700_r6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ijc.25373","article-title":"Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K\/AKT signaling in human hepatoma cell lines","volume":"128","author":"Li","year":"2011","journal-title":"Int. J. Cancer"},{"key":"2025030707475535700_r7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-3083.1986.tb01960.x","article-title":"Suppression by alpha-fetoprotein of murine natural killer cell activity stimulated in vitro and in vivo by interferon and interleukin 2","volume":"23","author":"Cohen","year":"1986","journal-title":"Scand. J. Immunol."},{"key":"2025030707475535700_r8","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1073\/pnas.73.8.2857","article-title":"Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes","volume":"73","author":"Yachnin","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707475535700_r9","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4049\/jimmunol.173.3.1772","article-title":"Alpha-fetoprotein impairs APC function and induces their apoptosis","volume":"173","author":"Um","year":"2004","journal-title":"J. Immunol."},{"key":"2025030707475535700_r10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.2011.04421.x","article-title":"\u03b1-Fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cells","volume":"165","author":"Yamamoto","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"2025030707475535700_r11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jhep.2004.08.013","article-title":"Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma","volume":"41","author":"Ritter","year":"2004","journal-title":"J. Hepatol."},{"key":"2025030707475535700_r12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2172-12-4","article-title":"Immunoregulatory effects of AFP domains on monocyte-derived dendritic cell function","volume":"12","author":"Setiyono","year":"2011","journal-title":"BMC Immunol."},{"key":"2025030707475535700_r13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4254\/wjh.v2.i7.256","article-title":"Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma","volume":"2","author":"Behboudi","year":"2010","journal-title":"World J. Hepatol."},{"key":"2025030707475535700_r14","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.4049\/jimmunol.166.8.5300","article-title":"T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein","volume":"166","author":"Butterfield","year":"2001","journal-title":"J. Immunol."},{"key":"2025030707475535700_r15","first-page":"5902","article-title":"T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer","volume":"9","author":"Butterfield","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"2025030707475535700_r16","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/1078-0432.CCR-05-2856","article-title":"A phase I\/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides","volume":"12","author":"Butterfield","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"2025030707475535700_r17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jim.2011.12.003","article-title":"Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients","volume":"376","author":"Potter","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"2025030707475535700_r18","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.3748\/wjg.v12.i20.3275","article-title":"Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma","volume":"12","author":"Ormandy","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"2025030707475535700_r19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/hep.20306","article-title":"Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease","volume":"40","author":"Wertheimer","year":"2004","journal-title":"Hepatology"},{"key":"2025030707475535700_r20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1479-5876-9-90","article-title":"Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines","volume":"9","author":"Lechner","year":"2011","journal-title":"J. Transl. Med."},{"key":"2025030707475535700_r21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4049\/jimmunol.156.1.322","article-title":"Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release","volume":"156","author":"Loetscher","year":"1996","journal-title":"J. Immunol."},{"key":"2025030707475535700_r22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4161\/onci.19788","article-title":"Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8\/IL-8 and CXCL10\/IP-10","volume":"1","author":"Vujanovic","year":"2012","journal-title":"OncoImmunology"},{"key":"2025030707475535700_r23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2025030707475535700_r24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-5793(95)00379-N","article-title":"Structural properties of alpha-fetoprotein from human cord serum: the protein molecule at low pH possesses all the properties of the molten globule","volume":"364","author":"Uversky","year":"1995","journal-title":"FEBS Lett."},{"key":"2025030707475535700_r25","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1073\/pnas.73.12.4645","article-title":"Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants","volume":"73","author":"Lester","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707475535700_r26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/jb\/mvn011","article-title":"Biological function of fucosylation in cancer biology","volume":"143","author":"Miyoshi","year":"2008","journal-title":"J. Biochem."},{"key":"2025030707475535700_r27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1440-1746.2000.02161.x","article-title":"Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection","volume":"15","author":"Kakumu","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2025030707475535700_r28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fimmu.2013.00192","article-title":"Tumor-altered dendritic cell function: implications for anti-tumor immunity","volume":"4","author":"Hargadon","year":"2013","journal-title":"Front. Immunol."},{"key":"2025030707475535700_r29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI9232","article-title":"A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense","volume":"105","author":"Salazar-Mather","year":"2000","journal-title":"J. Clin. Invest."},{"key":"2025030707475535700_r30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.clim.2008.08.012","article-title":"Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients","volume":"129","author":"Cai","year":"2008","journal-title":"Clin. Immunol."},{"key":"2025030707475535700_r31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/gutjnl-2011-300509","article-title":"Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma","volume":"61","author":"Chew","year":"2012","journal-title":"Gut"},{"key":"2025030707475535700_r32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ni.2538","article-title":"Distinct TCR signaling pathways drive proliferation and cytokine production in T cells","volume":"14","author":"Guy","year":"2013","journal-title":"Nat. Immunol."},{"key":"2025030707475535700_r33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.1983.tb32850.x","article-title":"Concanavalin-A-affinity molecular heterogeneity of human hepatoma AFP and cord-serum AFP","volume":"417","author":"Smith","year":"1983","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025030707475535700_r34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4615-1891-4_27","article-title":"Evidence that immunosuppression is an intrinsic property of the alpha-fetoprotein molecule","volume":"383","author":"Semeniuk","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"key":"2025030707475535700_r35","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0021-9258(17)38047-X","article-title":"The presence of fatty acids in human alpha-fetoprotein","volume":"253","author":"Parmelee","year":"1978","journal-title":"J. Biol. Chem."},{"key":"2025030707475535700_r36","first-page":"3571","article-title":"alpha-Fetoprotein as a carrier protein in plasma and its bilirubin-binding ability","volume":"39","author":"Aoyagi","year":"1979","journal-title":"Cancer Res."},{"key":"2025030707475535700_r37","doi-asserted-by":"crossref","first-page":"14293","DOI":"10.1074\/jbc.M410000200","article-title":"Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation","volume":"280","author":"Zeyda","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2025030707475535700_r38","first-page":"251","article-title":"Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency","volume":"48","author":"Widner","year":"2000","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"2025030707475535700_r39","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.4049\/jimmunol.181.3.1887","article-title":"Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis","volume":"181","author":"Liu","year":"2008","journal-title":"J. Immunol."},{"key":"2025030707475535700_r40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1006\/bbrc.1993.2357","article-title":"The fatty acid binding site of human alpha-fetoprotein","volume":"196","author":"Nishihira","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025030707475535700_r41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pep.2004.07.007","article-title":"Purification and characterization of a recombinant version of human alpha-fetoprotein expressed in the milk of transgenic goats","volume":"38","author":"Parker","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"2025030707475535700_r42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/onci.1.1.18344","article-title":"Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities","volume":"1","author":"Pardee","year":"2012","journal-title":"OncoImmunology"},{"key":"2025030707475535700_r43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/01.cji.0000171291.72039.e2","article-title":"Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial","volume":"28","author":"Lee","year":"2005","journal-title":"J. Immunother."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/11\/5723\/62227526\/1400725.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/11\/5723\/62227526\/1400725.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:19:23Z","timestamp":1741335563000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/193\/11\/5723\/7967172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1400725","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,12]]},"published":{"date-parts":[[2014,12,1]]}}}